244 related articles for article (PubMed ID: 11685209)
1. MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation.
Trockenbacher A; Suckow V; Foerster J; Winter J; Krauss S; Ropers HH; Schneider R; Schweiger S
Nat Genet; 2001 Nov; 29(3):287-94. PubMed ID: 11685209
[TBL] [Abstract][Full Text] [Related]
2. MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders.
Short KM; Hopwood B; Yi Z; Cox TC
BMC Cell Biol; 2002; 3():1. PubMed ID: 11806752
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation and microtubule association of the Opitz syndrome protein mid-1 is regulated by protein phosphatase 2A via binding to the regulatory subunit alpha 4.
Liu J; Prickett TD; Elliott E; Meroni G; Brautigan DL
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6650-5. PubMed ID: 11371618
[TBL] [Abstract][Full Text] [Related]
4. Mig12, a novel Opitz syndrome gene product partner, is expressed in the embryonic ventral midline and co-operates with Mid1 to bundle and stabilize microtubules.
Berti C; Fontanella B; Ferrentino R; Meroni G
BMC Cell Biol; 2004 Feb; 5():9. PubMed ID: 15070402
[TBL] [Abstract][Full Text] [Related]
5. Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A.
Aranda-Orgillés B; Aigner J; Kunath M; Lurz R; Schneider R; Schweiger S
PLoS One; 2008; 3(10):e3507. PubMed ID: 18949047
[TBL] [Abstract][Full Text] [Related]
6. The MID1/PP2A complex: a key to the pathogenesis of Opitz BBB/G syndrome.
Schweiger S; Schneider R
Bioessays; 2003 Apr; 25(4):356-66. PubMed ID: 12655643
[TBL] [Abstract][Full Text] [Related]
7. MID1 catalyzes the ubiquitination of protein phosphatase 2A and mutations within its Bbox1 domain disrupt polyubiquitination of alpha4 but not of PP2Ac.
Du H; Wu K; Didoronkute A; Levy MV; Todi N; Shchelokova A; Massiah MA
PLoS One; 2014; 9(9):e107428. PubMed ID: 25207814
[TBL] [Abstract][Full Text] [Related]
8. The Opitz syndrome gene product MID1 assembles a microtubule-associated ribonucleoprotein complex.
Aranda-Orgillés B; Trockenbacher A; Winter J; Aigner J; Köhler A; Jastrzebska E; Stahl J; Müller EC; Otto A; Wanker EE; Schneider R; Schweiger S
Hum Genet; 2008 Mar; 123(2):163-76. PubMed ID: 18172692
[TBL] [Abstract][Full Text] [Related]
9. Developmental expression of alpha4 protein phosphatase regulatory subunit in tissues affected by Opitz syndrome.
Everett AD; Brautigan DL
Dev Dyn; 2002 Aug; 224(4):461-4. PubMed ID: 12203739
[TBL] [Abstract][Full Text] [Related]
10. Alpha4 is a ubiquitin-binding protein that regulates protein serine/threonine phosphatase 2A ubiquitination.
McConnell JL; Watkins GR; Soss SE; Franz HS; McCorvey LR; Spiller BW; Chazin WJ; Wadzinski BE
Biochemistry; 2010 Mar; 49(8):1713-8. PubMed ID: 20092282
[TBL] [Abstract][Full Text] [Related]
11. The MID1 E3 ligase catalyzes the polyubiquitination of Alpha4 (α4), a regulatory subunit of protein phosphatase 2A (PP2A): novel insights into MID1-mediated regulation of PP2A.
Du H; Huang Y; Zaghlula M; Walters E; Cox TC; Massiah MA
J Biol Chem; 2013 Jul; 288(29):21341-21350. PubMed ID: 23740247
[TBL] [Abstract][Full Text] [Related]
12. Monoubiquitination promotes calpain cleavage of the protein phosphatase 2A (PP2A) regulatory subunit α4, altering PP2A stability and microtubule-associated protein phosphorylation.
Watkins GR; Wang N; Mazalouskas MD; Gomez RJ; Guthrie CR; Kraemer BC; Schweiger S; Spiller BW; Wadzinski BE
J Biol Chem; 2012 Jul; 287(29):24207-15. PubMed ID: 22613722
[TBL] [Abstract][Full Text] [Related]
13. The E3 ubiquitin ligase MID1/TRIM18 promotes atypical ubiquitination of the BRCA2-associated factor 35, BRAF35.
Zanchetta ME; Napolitano LMR; Maddalo D; Meroni G
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1844-1854. PubMed ID: 28760657
[TBL] [Abstract][Full Text] [Related]
14. The Opitz syndrome gene product, MID1, associates with microtubules.
Schweiger S; Foerster J; Lehmann T; Suckow V; Muller YA; Walter G; Davies T; Porter H; van Bokhoven H; Lunt PW; Traub P; Ropers HH
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2794-9. PubMed ID: 10077590
[TBL] [Abstract][Full Text] [Related]
15. Progestin-inducible EDD E3 ubiquitin ligase binds to α4 phosphoprotein to regulate ubiquitination and degradation of protein phosphatase PP2Ac.
McDonald WJ; Thomas LN; Koirala S; Too CKL
Mol Cell Endocrinol; 2014 Jan; 382(1):254-261. PubMed ID: 24145130
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of midline defect-causing mutation P151L in MID1 revealed.
Nicholson LK
FEBS J; 2017 Jul; 284(14):2167-2169. PubMed ID: 28714291
[TBL] [Abstract][Full Text] [Related]
17. Overlapping binding sites in protein phosphatase 2A for association with regulatory A and alpha-4 (mTap42) subunits.
Prickett TD; Brautigan DL
J Biol Chem; 2004 Sep; 279(37):38912-20. PubMed ID: 15252037
[TBL] [Abstract][Full Text] [Related]
18. Control of mTORC1 signaling by the Opitz syndrome protein MID1.
Liu E; Knutzen CA; Krauss S; Schweiger S; Chiang GG
Proc Natl Acad Sci U S A; 2011 May; 108(21):8680-5. PubMed ID: 21555591
[TBL] [Abstract][Full Text] [Related]
19. FXY2/MID2, a gene related to the X-linked Opitz syndrome gene FXY/MID1, maps to Xq22 and encodes a FNIII domain-containing protein that associates with microtubules.
Perry J; Short KM; Romer JT; Swift S; Cox TC; Ashworth A
Genomics; 1999 Dec; 62(3):385-94. PubMed ID: 10644436
[TBL] [Abstract][Full Text] [Related]
20. Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1).
Aranda-Orgillés B; Rutschow D; Zeller R; Karagiannidis AI; Köhler A; Chen C; Wilson T; Krause S; Roepcke S; Lilley D; Schneider R; Schweiger S
J Biol Chem; 2011 Nov; 286(46):39945-57. PubMed ID: 21930711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
